Not checked for notices yet.
Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells
James Hodge, Jay Friedman, Michelle R Padget and 9 more
Journal for ImmunoTherapy of Cancer · 2021
Cited by papers we hold 3
- Development of NK cell-based cancer immunotherapies through receptor engineering · 2024No notice
- Emerging Targeted Therapies for HER2-Positive Breast Cancer · 2023No notice
- CAR-NK Cells in the Treatment of Solid Tumors · 2021No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.